WINDLAS Q1 FY27 results at a glance
WINDLAS BIOTECH LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹248 cr |
|---|
| Revenue YoY | +18.1% |
|---|
| Operating profit | ₹19.47 cr |
|---|
| Operating margin | 7.8% |
|---|
| Net profit | ₹17.65 cr |
|---|
| Net profit YoY | -0.1% |
|---|
| Net profit QoQ | +10.4% |
|---|
| Net margin | 7.1% |
|---|
| Basic EPS | ₹8.46 |
|---|
| TTM revenue | ₹942 cr |
|---|
| TTM net profit | ₹66.45 cr |
|---|
| TTM net margin | 7.1% |
|---|
WINDLAS Q1 FY27 results: what the numbers say
WINDLAS BIOTECH LIMITED (WINDLAS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹248 cr and a net profit of ₹17.65 cr, translating into earnings per share of ₹8.46.
Compared with the same quarter a year earlier, revenue grew by +18.1% and net profit declined marginally by -0.1%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹19.47 cr, an operating margin of 7.8% versus 9.1% a year ago — a contraction of 1.2 percentage points.
WINDLAS quarter-wise results table
Net profit
₹17.65 cr
-0.1% YoY
Operating profit
₹19.47 cr
+2.1% YoY
WINDLAS BIOTECH LIMITED (WINDLAS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹248 cr | ₹19.47 cr | ₹17.65 cr | 7.8% | 7.1% | ₹8.46 | -0.1% | +10.4% |
| Q4 FY262026-03-31 | ₹238 cr | ₹17.29 cr | ₹15.99 cr | 7.2% | 6.7% | ₹7.58 | — | +6.6% |
| Q3 FY262025-12-31 | ₹233 cr | ₹16.68 cr | ₹15 cr | 7.2% | 6.4% | ₹7.12 | — | -15.7% |
| Q2 FY262025-09-30 | ₹222 cr | ₹20.96 cr | ₹17.8 cr | 9.4% | 8.0% | ₹8.48 | — | +0.8% |
| Q1 FY262025-06-30 | ₹210 cr | ₹19.08 cr | ₹17.67 cr | 9.1% | 8.4% | ₹8.43 | — | — |
| TTM (last 4 quarters) | ₹942 cr | ₹74.4 cr | ₹66.45 cr | 7.9% | 7.1% | ₹31.64 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
WINDLAS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
WINDLAS BIOTECH LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹248 cr | ₹238 cr | ₹233 cr | ₹222 cr | ₹210 cr |
|---|
| Total expenses | ₹229 cr | ₹221 cr | ₹216 cr | ₹201 cr | ₹191 cr |
|---|
| Gross profit | ₹95.37 cr | ₹91.45 cr | ₹89.6 cr | ₹85.45 cr | ₹80.36 cr |
|---|
| Operating profit (EBIT) | ₹19.47 cr | ₹17.29 cr | ₹16.68 cr | ₹20.96 cr | ₹19.08 cr |
|---|
| Operating margin | 7.8% | 7.2% | 7.2% | 9.4% | 9.1% |
|---|
| Interest cost | ₹1.65 cr | ₹1.48 cr | ₹1.28 cr | ₹1.02 cr | ₹1.06 cr |
|---|
| Profit before tax | ₹22.94 cr | ₹20.16 cr | ₹19.97 cr | ₹23.59 cr | ₹23.26 cr |
|---|
| Tax expense | ₹5.28 cr | ₹4.17 cr | ₹4.97 cr | ₹5.79 cr | ₹5.59 cr |
|---|
| Effective tax rate | 23.0% | 20.7% | 24.9% | 24.5% | 24.0% |
|---|
| Net profit (PAT) | ₹17.65 cr | ₹15.99 cr | ₹15 cr | ₹17.8 cr | ₹17.67 cr |
|---|
| Net profit margin | 7.1% | 6.7% | 6.4% | 8.0% | 8.4% |
|---|
| Basic EPS | ₹8.46 | ₹7.58 | ₹7.12 | ₹8.48 | ₹8.43 |
|---|
| Diluted EPS | ₹8.32 | ₹7.49 | ₹7.05 | ₹8.40 | ₹8.34 |
|---|
WINDLAS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +18.1% | — | — | — | — |
|---|
| Revenue QoQ | +4.0% | +2.3% | +4.8% | +5.9% | — |
|---|
| Operating profit YoY | +2.1% | — | — | — | — |
|---|
| Operating profit QoQ | +12.7% | +3.6% | -20.4% | +9.9% | — |
|---|
| Net profit YoY | -0.1% | — | — | — | — |
|---|
| Net profit QoQ | +10.4% | +6.6% | -15.7% | +0.8% | — |
|---|
| EPS YoY | +0.4% | — | — | — | — |
|---|
| EPS QoQ | +11.6% | +6.5% | -16.0% | +0.6% | — |
|---|
WINDLAS annual results history
Full-year performance for WINDLAS BIOTECH LIMITED, useful for reading each quarter in context.
WINDLAS BIOTECH LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹898 cr | ₹755 cr | ₹629 cr | ₹511 cr |
|---|
| Total expenses | ₹823 cr | ₹689 cr | ₹564 cr | ₹463 cr |
|---|
| Gross profit | ₹340 cr | ₹283 cr | ₹233 cr | ₹185 cr |
|---|
| Operating profit (EBIT) | ₹74.23 cr | ₹66.61 cr | ₹64.73 cr | ₹47.92 cr |
|---|
| Operating margin | 8.3% | 8.8% | 10.3% | 9.4% |
|---|
| Interest cost | ₹4.83 cr | ₹4.38 cr | ₹1.11 cr | ₹0.79 cr |
|---|
| Profit before tax | ₹86.98 cr | ₹79.76 cr | ₹77.09 cr | ₹57.04 cr |
|---|
| Tax expense | ₹20.52 cr | ₹18.76 cr | ₹18.9 cr | ₹14.41 cr |
|---|
| Effective tax rate | 23.6% | 23.5% | 24.5% | 25.3% |
|---|
| Net profit (PAT) | ₹66.46 cr | ₹60.99 cr | ₹58.19 cr | ₹42.63 cr |
|---|
| Net profit margin | 7.4% | 8.1% | 9.3% | 8.3% |
|---|
| Basic EPS | ₹31.60 | ₹29.19 | ₹27.97 | ₹19.70 |
|---|
| Diluted EPS | ₹31.15 | ₹28.87 | ₹27.88 | ₹19.70 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹248 cr against ₹210 cr in Q1 FY26, and ₹238 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +4.0%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹229 cr, or 92.2% of revenue, with operating profit grew +2.1% year on year.
Margins, tax and profitability
Net profit of ₹17.65 cr works out to a net margin of 7.1% compared with 8.4% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, WINDLAS BIOTECH LIMITED reported profit before tax of ₹22.94 cr, a tax charge of ₹5.28 cr (effective rate 23.0%), interest cost of ₹1.65 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹15.99 cr in Q4 FY26 to ₹17.65 cr in Q1 FY27, a change of +10.4%.
Trailing twelve months and annual context
Across the trailing four quarters WINDLAS BIOTECH LIMITED has generated revenue of ₹942 cr and net profit of ₹66.45 cr, a trailing net margin of 7.1%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹898 cr with net profit of ₹66.46 cr and EPS of ₹31.60, versus the prior year where revenue grew +18.9% and profit grew +9.0%.
What to watch in the next WINDLAS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
WINDLAS BIOTECH LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
WINDLAS results coverage
No results report published for WINDLAS yet — our desk covers each quarter within minutes of the filing.
WINDLAS quarterly results FAQs
What were WINDLAS BIOTECH LIMITED (WINDLAS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), WINDLAS BIOTECH LIMITED reported revenue of ₹248 cr and net profit of ₹17.65 cr, a change of -0.1% year on year on +18.1% revenue growth. EPS stood at ₹8.46.
What is WINDLAS profit margin in Q1 FY27?
WINDLAS BIOTECH LIMITED posted a net profit margin of 7.1% and an operating margin of 7.8% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹942 cr and net profit ₹66.45 cr.
Did WINDLAS results beat the previous quarter?
WINDLAS BIOTECH LIMITED net profit changed +10.4% quarter on quarter, from ₹15.99 cr in Q4 FY26 to ₹17.65 cr in Q1 FY27.
When are WINDLAS BIOTECH LIMITED (WINDLAS) quarterly results?
WINDLAS BIOTECH LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see WINDLAS latest quarterly results?
Results coverage for WINDLAS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the WINDLAS stock page.
What is WINDLAS BIOTECH LIMITED annual revenue and profit?
For FY26, WINDLAS BIOTECH LIMITED reported full-year revenue of ₹898 cr and net profit of ₹66.46 cr, with EPS of ₹31.60.
How many quarterly results has WINDLAS declared recently?
Past results dates for WINDLAS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
